Parker Waichman LLP

Former InterMune CEO Indicted for Promoting Actimmune

InterMune Inc.’s former chief executive officer, Scott Harkonen, was indicted on Tuesday for falsely promoting the company’s drug <“https://www.yourlawyer.com/practice_areas/defective_drugs”>Actimmune as a treatment for the fatal lung disease idiopathic pulmonary fibrosis (IPF) the Justice Department said on Tuesday. Acctimmune is a genetically engineered form of the protein interferon gamma which stimulates the human immune system.  Actimmune […]

InterMune Inc.’s former chief executive officer, Scott Harkonen, was indicted on Tuesday for falsely promoting the company’s drug <“https://www.yourlawyer.com/practice_areas/defective_drugs”>Actimmune as a treatment for the fatal lung disease idiopathic pulmonary fibrosis (IPF) the Justice Department said on Tuesday.

Acctimmune is a genetically engineered form of the protein interferon gamma which stimulates the human immune system.  Actimmune was approved by the US Food and Drug Administration (FDA) only for use in children and adults with chronic granulomatous disease (CGD) and severe, malignant osteopetrosis.

CGD is comprised of a group of inherited immune system disorders caused by defects in immune cells called phagocytes.  These cells recognize and destroy microbial pathogens.  In patients with CGD, phagocytes do not generate sufficient levels of the enzymes responsible for killing ingested microorganisms, leaving patients vulnerable to severe, recurrent bacterial and fungal infections and chronic inflammatory conditions like gingivitis, enlarged lymph glands, and tumor-like masses called granulomas. While not malignant, granulomas can cause serious problems by reducing airflow in the lungs, obstructing the passage of food through the gastrointestinal system, and preventing the flow of urine through the kidneys and bladder.  Granulomas are a major recurring feature chronic granulomatous disease.  In severe, malignant osteopetrosis—a rare life-threatening congenital disorder—the patient develops abnormally dense and brittle bone structures, which compromises bone marrow space and impairs cranial nerve function.
As a result, patients have an increased risk of anemia, blindness, hearing loss, and infection.  Actimmune acts to prevent infection in these patients.

Federal prosecutors alleged that under former CEO Scott Harkonen’s direction, InterMune put out a press release in 2002 stating that a clinical trial showed that Actimmune was effective in the treatment of IPF.  IPF is a life-threatening scarring of the lung tissue in which the air sacs of the lungs become replaced by fibrotic tissue.  When the scar forms, the tissue becomes thicker, causing an irreversible loss of the tissue’s ability to transfer oxygen into the bloodstream.  There are currently neither any effective treatments nor a cure for Idiopathic Pulmonary Fibrosis.

The indictment states that in the clinical trial, Actimmune was ineffective in treating IPF.  “The vast majority of InterMune’s sales of Actimmune were for the unapproved, off-label use of treating IPF,” the indictment said. “The cost of Actimmune for one IPF patient for one year was approximately $50,000.”  Off-label uses are permissible with physician discretion; however, drug makers are prohibited by law from marketing drugs for off-label uses.

Harkonen’s lawyer said his client was innocent of the charges against him.  “The New England Journal of Medicine published a twelve-month study stating that Actimmune was associated with substantial improvements in the condition of IPF patients,” said lawyer James Brosnahan. “There were additional extensive clinical studies and at all times (Food and Drug Administration) approval was diligently pursued.”

Harkonen is charged with wire fraud and fraud in connection with medical drug sales. If he is convicted on all charges, Harkonen could be sentenced to 23 years in prison.  In October 2006, InterMune agreed to pay nearly $37 million to resolve criminal and civil charges in connection with the case.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Thank you Parker you are the best in town. I’m super happy with your services.I will recommend my friends and family. Jorge thank you for everything you did for me
Edgar Fortiz
4 years ago
5 Star Reviews 150
Thank you parker waichman for settling my case big thanks to bret anick who put all efforts andhard work to get to this point Thanks again guys
Timothy Torres
6 years ago
5 Star Reviews 150
Kelli Alexander is your employee, we have been dealing with her for years. Our case just concluded. Parker Waichman has been a wonderful representative. But Kelli Alexander has been your greatest asset. Our calls promptly returned. Any question answered quicky. She has been kind courteous. and professional, at all times you are lucky to have her in you employment.
Donna Giambalvo
4 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038